According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.97 Billion. a decrease over its 2023 earnings that were of C$3.26 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | C$3.20 B | -1.9% |
2023 | C$3.26 B | -28.11% |
2022 | C$4.54 B | -41.15% |
2021 | C$7.72 B | 78.15% |
2020 | C$4.33 B | 246.83% |
2019 | C$1.25 B | -48.74% |
2018 | C$2.43 B | -23.86% |
2017 | C$3.20 B | 21.77% |
2016 | C$2.63 B | -253.22% |
2015 | -C$1.72 Billion | -159.7% |
2014 | C$2.87 B | 12.76% |
2013 | C$2.55 B | 2.7% |
2012 | C$2.48 B | -57.11% |
2011 | C$5.79 B | -10.11% |
2010 | C$6.44 B | -4.2% |
2009 | C$6.72 B |